Integrated Core Strategies (US) LLC 13D and 13G filings for Kala Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-16 4:11 pm Purchase |
2024-02-09 | 13G | Kala Pharmaceuticals, Inc. KALA |
Integrated Core Strategies (US) LLC | 135,096 5.000% |
135,096 (New Position) |
Filing |